DMRA
Damora Therapeutics, Inc.
20.70$
-0.4%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Damora Therapeutics, Inc. (DMRA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -6.7 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -14 | -19 | -38 | -52 | -43 | -37 | -19 | -6.7 | |
| – | 0.1 | 0.2 | 0.4 | 0.5 | 0.8 | 0.2 | 0.0 | |
| – | – | – | 4.5 | 5.6 | 5.4 | 3.2 | 1.0 | |
| -0.9 | 2.2 | -4.6 | -6.6 | 12 | -4.4 | -2.7 | 18 | |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | |
| – | -0.3 | – | -48 | 12 | 22 | 12 | -17 | |
| 43 | – | 187 | 0.0 | 0.5 | 2.9 | 0.0 | 267 | |
| 31 | -20 | 152 | -101 | -30 | -11 | -7.3 | 243 | |
| -14 | -19 | -38 | -53 | -43 | -37 | -19 | -6.7 |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.